NCT05722535 Using Shared Decision Making to Improve Family Media Use Planning
| NCT ID | NCT05722535 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seattle Children's Hospital |
| Condition | Adolescent Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2022-07-10 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2022-07-10 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigators will conduct a pilot randomized controlled trial assessing the efficacy and feasibility of the newly developed Family Media Check-In (FMC).
Eligibility Criteria
Inclusion Criteria: * Children between the ages of 11 and 17 * Parent/guardian of a child between the ages of 11 and 17 * English speaking Exclusion Criteria: * Parent/guardian or child does not want to participate (i.e., dyads only) * Non-English speaking
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05722535 clinical trial?
This trial is open to participants of all sexes, aged 11 Years or older, studying Adolescent Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05722535 currently recruiting?
Yes, NCT05722535 is actively recruiting participants. Contact the research team at emily.kroshus@seattlechildrens.org for enrollment information.
Where is the NCT05722535 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT05722535 clinical trial?
NCT05722535 is sponsored by Seattle Children's Hospital. The trial plans to enroll 300 participants.